The Authors League Fund provides assistance to book authors, dramatists, and freelance writers, including journalists and poets. Recipients must fall into one or more of the following categories:
- Book authors with at least one title published by an established, traditional publisher. Authors with a substantial body of work are given priority. (Writers who have found financial and/or professional success through indie or subsidiary publishing may be considered, although typically the Fund does not assist writers whose credits are solely self-published.)
- Dramatists whose full-length plays have been produced in theaters with at least 200 seats and/or published by established dramatic presses.
- Journalists and freelance writers who have published at least ten articles in publications with a national or broad circulation. Online publications must be with websites that have strong editorial oversight and a sizable readership.
The applicant’s status as a professional writer is vital. While it is not necessary that the applicant subsists solely on his or her income from writing, or publish often, it is important that his or her writing credits be accomplished.
We encourage you to email us with questions about eligibility.
Common applicants include:
- Writers of any age in ill health or supporting a dependent family member in ill health.
- Writers facing overwhelming medical or dental expenses.
- Writers suffering financial crises unrelated to health, such as unexpected loss of income, temporary unemployment or underemployment, eviction proceedings, or similar.
Priority is given to sick and/or older authors in need. Family members or close friends of writers suffering from cognitive decline may assist with the application process. Please contact the office for guidance.
Because the Fund seeks to help as many qualified applicants as possible, the assistance offered is temporary in nature. Recipients may apply again after a period of twelve months has passed, with some exceptions made under the most extreme circumstances.